Hey Pattsy yes still holding. I believe management and the team are working hard on all parts of getting trials up and running but also the new inhaler part of the business model which potentially has some serious applications including potential around COVID symptoms. The next 3>6 months could see some huge milestones achieved and a serious re-rate. Tough market currently across all sectors but IHL a real potential standout for whats in the news flow pipeline in 2020.
IHL Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held
